Evidence map›Paper›PMID 26310111›Full record

ArticleNature communications2015

Mitochondrial uncoupling links lipid catabolism to Akt inhibition and resistance to tumorigenesis.

Sara M Nowinski, Ashley Solmonson, Joyce E Rundhaug, Okkyung Rho, Jiyoon Cho, Cory U Lago, Christopher L Riley, Sunhee Lee, Shohei Kohno, Christine K Dao and 6 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 29 citations in OpenAlex.

  1. Mitochondria as a Therapeutic Target in Metabolic Disorders.Mini reviews in medicinal chemistry · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Sara M NowinskiDivision of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, Texas 78712, USA.
Ashley SolmonsonCenter for Molecular and Cellular Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, Texas 78712, USA.
Joyce E RundhaugScience Park Research Division, University of Texas MD Anderson Cancer Center, Smithville, Texas 78957, USA.
Okkyung RhoDivision of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, Texas 78712, USA.
Jiyoon ChoDivision of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, Texas 78712, USA.
Cory U LagoCenter for Molecular Medicine, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Christopher L RileyInstitute for Cellular and Molecular Biology, The University of Texas at Austin, Austin, Texas 78712, USA.
Sunhee LeeInstitute for Cellular and Molecular Biology, The University of Texas at Austin, Austin, Texas 78712, USA.
Shohei KohnoDivision of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, Texas 78712, USA.
Christine K DaoDivision of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, Texas 78712, USA.
Takeshi NikawaDepartment of Nutritional Physiology, Institute of Health Biosciences, Tokushima University Graduate School, Tokushima 770-8503, Japan.
Shawn B BrattonScience Park Research Division, University of Texas MD Anderson Cancer Center, Smithville, Texas 78957, USA.
Casey W WrightDivision of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, Texas 78712, USA.
Susan M FischerScience Park Research Division, University of Texas MD Anderson Cancer Center, Smithville, Texas 78957, USA.
John DiGiovanniDivision of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, Texas 78712, USA.
Edward M MillsDivision of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, Texas 78712, USA.
The University of Texas at Austin · USThe University of Texas MD Anderson Cancer Center · USAustin College · USNational Heart Lung and Blood Institute · USTokushima University · JP

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Pilot Project ProgramP30ES007784 · NIEHS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI RICHIE, ELLEN R · 1996 to 2011
$16.4M
Interdisciplinary Training Program in MetabolismT32DK091317 · NIDDK · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI SCOTT A SUMMERS · 2011 to 2026
$4.8M
Molecular mechanisms of thermogenesisR01DK089224 · NIDDK · UNIVERSITY OF TEXAS AT AUSTIN · PI DIGIOVANNI, JOHN · 2011 to 2023
$3.4M
Molecular mechanisms of thermogenesisR56DK089224 · NIDDK · UNIVERSITY OF TEXAS AT AUSTIN · PI MILLS, EDWARD M · 2017 to 2017
$229k
NIDDK NIH HHS DK089224NIDDK NIH HHS R01 DK089224NIDDK NIH HHS R56 DK089224NIDDK NIH HHS T32 DK 091317NIDDK NIH HHS T32 DK091317NIEHS NIH HHS ES007784NIEHS NIH HHS P30 ES007784NIEHS NIH HHS T32 ES0247
6 · The paper itself

Abstract

To support growth, tumour cells reprogramme their metabolism to simultaneously upregulate macromolecular biosynthesis while maintaining energy production. Uncoupling proteins (UCPs) oppose this phenotype by inducing futile mitochondrial respiration that is uncoupled from ATP synthesis, resulting in nutrient wasting. Here using a UCP3 transgene targeted to the basal epidermis, we show that forced mitochondrial uncoupling inhibits skin carcinogenesis by blocking Akt activation. Similarly, Akt activation is markedly inhibited in UCP3 overexpressing primary human keratinocytes. Mechanistic studies reveal that uncoupling increases fatty acid oxidation and membrane phospholipid catabolism, and impairs recruitment of Akt to the plasma membrane. Overexpression of Akt overcomes metabolic regulation by UCP3, rescuing carcinogenesis. These findings demonstrate that mitochondrial uncoupling is an effective strategy to limit proliferation and tumorigenesis through inhibition of Akt, and illuminate a novel mechanism of crosstalk between mitochondrial metabolism and growth signalling.

Indexed as

AnimalsCarcinogenesisCarcinogensCell ProliferationFlow CytometryGene OntologyHumansImmunoblottingIon ChannelsKeratinocytesLipid MetabolismMetabolomeMetabolomicsMiceMice, TransgenicMitochondriaCarcinogensIon ChannelsMitochondrial ProteinsProto-Oncogene Proteins c-aktReactive Oxygen SpeciesTetradecanoylphorbol AcetateUCP3 protein, humanUcp3 protein, mouseUncoupling Protein 3

Identifiers

PMID26310111
PMCPMC4552083
OpenAlexW2264184249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.